UK: Delay in meningitis vaccine will cost
Created 05/08/2014 - 04:45
- Campaigners in the UK have warned that the delay in introducing a new vaccine against meningitis will cost lives, The Telegraph reported Thursday.
- In January 2013, Meningitis B vaccine, Bexsero, was licensed by the EU and the UK Joint Committe on Vaccination and Immunisation approved the vaccine for NHS use in March if it could be obtained at a suitable price.
- Andy Hopkinson, of charity, Meningitis Now (UK), said that "we hope negotiations between the UK Department of Health and the vaccine company will be concluded swiftly."
- Division head of Novartis Vaccines, Andrin Oswald, asked the government to act swiftly to "avoid further loss of lives and patient suffering."
- He added that "we are willing to work with the UK government on the next steps and are waiting for the public procurement process to start."